Prediction of methotrexate responsiveness of tumors in man.
D004273:DNA, Neoplasm / Q000096:biosynthesis; D003857:Deoxyuridine / Q000378:metabolism; D004351:Drug Resistance; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000201:enzymology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000201:enzymology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D011379:Prognosis; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D004273:DNA, Neoplasm; D014316:Tritium; D013762:Tetrahydrofolate Dehydrogenase; D013936:Thymidine; D003857:Deoxyuridine; D008727:Methotrexate